Toward Future Adaptive Deep Brain Stimulation For Parkinson'S Disease: The Novel Biomarker - Narrowband Gamma Oscillation

Parkinson’s disease（PD） is one of the most common neurodegenerative diseases,affecting individuals especially over 60 years of age.In the next three decades,more than 12 million people will suffer from PD worldwide（Rocca,2018）.The characteristic symptoms of PD begin as a movement disorder including bradykinesia,resting tremor,rigidity,and postural instability.Among these symptoms,